Welcome to our dedicated page for Axt SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AXT, Inc. (AXTI) SEC filings page brings together the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, AXT submits periodic and current reports that describe its financial condition, operations and material events related to its business of developing and manufacturing compound and single element semiconductor substrate wafers.
Through this page, investors can access annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide detailed financial statements, management discussion and analysis, and information about AXT’s substrate products based on indium phosphide, gallium arsenide and germanium. These filings also describe risk factors, business segments, manufacturing footprint in China and the role of its subsidiary Beijing Tongmei Xtal Technology Co., Ltd.
AXT’s current reports on Form 8-K document material events such as quarterly earnings announcements, preliminary revenue ranges, export control developments affecting indium phosphide and gallium arsenide shipments, capital-raising transactions under its Form S-3 shelf registration statement, and corporate governance matters including board changes and Nasdaq listing rule compliance. Some 8-Ks incorporate press releases as exhibits, giving additional context to the headline events.
Investors can also review registration statements and prospectus supplements related to AXT’s public offerings of common stock, which outline the terms of the offerings and the company’s stated use of proceeds, including plans to increase manufacturing capacity at Tongmei, fund research and development and support general corporate purposes.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and help explain complex topics such as revenue drivers, export control impacts, capital structure changes and audit committee disclosures. Real-time updates from EDGAR ensure that new AXTI filings, including Forms 10-K, 10-Q, 8-K and registration-related documents, are available promptly, while insider transaction reports on Form 4 can be monitored alongside these core filings.
AXT, Inc. filed a current report describing an update to its expected results for the fourth quarter of 2025. On January 8, 2026, the company issued a press release that revised its revenue expectations for the quarter ended December 31, 2025 and announced the planned date for its upcoming earnings release.
The filing states that the press release contains certain unaudited financial information for the fourth quarter. This information, included as Exhibit 99.1, is being furnished rather than filed, which limits how it is treated under securities laws. No detailed financial figures are included in the text of the report itself.
AXT Inc's CEO filed a Form 4 reporting an insider stock gift. On 12/09/2025, a transaction coded “G” transferred 7,800 shares of common stock at a price of $0.
After this transaction, a total of 2,450,604 AXT Inc common shares were beneficially owned indirectly through the Young Family Trust DTD. The filing was made by one reporting person and signed by attorney-in-fact Jeff Sensiba.
AXT Inc. (AXTI) CEO reported charitable-style transfers of company stock in a Form 4 filing. On 11/21/2025, the reporting person made two transactions coded as gifts, disposing of 12,000 shares and 3,000 shares of AXT common stock at a reported price of $0 per share.
After these transactions, the reporting person beneficially owned 2,461,360 shares of AXT common stock indirectly through the Young Family Trust DTD. The filing is an ownership disclosure and does not describe any change in the company’s operations or financial performance.
AXT Inc. (AXTI) CEO stock sale reported
The CEO of AXT Inc. reported selling 33,130 shares of the company’s common stock on 11/17/2025. The sale is coded as transaction type “S,” which indicates an open-market or private sale transaction. The weighted average sale price was $10.395 per share, with individual trades executed between $10.15 and $10.81 per share.
After this transaction, the reporting person beneficially owns 2,476,360 shares of AXT common stock in direct ownership form. The filer notes that detailed trade information for each price level is available upon request by regulators, the company, or its shareholders.
AXT Inc. (AXTI) CEO stock transaction: The company’s chief executive officer reported exercising stock options for 70,000 shares of common stock on 11/14/2025 at an exercise price of $5.21 per share. These options were originally granted on 10/28/2016 and first became exercisable on 10/28/2017. Following this transaction, the CEO directly beneficially owns 2,509,490 shares of AXT common stock and holds 621,953 stock options for common shares.
AXT Inc (AXTI) disclosed an insider transaction on a Form 4: the CFO sold 101,297 shares of common stock on 11/13/2025 at a weighted average price of $10.138, with individual trades between $10.05 and $10.28. After these sales, the reporting person beneficially owned 361,997 shares, held directly. The filing states full trade-by-trade details are available upon request.
AXT, Inc. reported Q3 2025 results showing year-over-year improvement in the quarter but weaker performance year to date. Revenue was $27.955 million versus $23.645 million a year ago, and gross profit rose to $6.224 million from $5.682 million. The net loss attributable to AXT narrowed to $1.906 million from $2.937 million, or ($0.04) per share compared with ($0.07). For the nine months, revenue was $65.285 million versus $74.256 million, and the net loss widened to $17.712 million.
Cash and cash equivalents were $23.110 million with $8.100 million of restricted cash. Inventories declined to $77.656 million, while accounts receivable increased to $33.837 million. Short‑term loans rose to $61.547 million. Total assets were $334.034 million, and total stockholders’ equity was $202.345 million. AXT remains the controlling stakeholder of Tongmei; noncontrolling and redeemable noncontrolling interests together were approximately 14.5% as of September 30, 2025. The company’s investment in Jia Mei was $702,000 after a fair value loss and subsequent gain recognized during Q2–Q3.
AXT Inc. (AXTI) reported an insider transaction on Form 4. A director sold 3,637 shares of common stock on 11/07/2025 at $8.41 per share.
Following the sale, the reporting person directly owns 118,875 shares. The filing was signed by attorney-in-fact Jeff Sensiba on 11/10/2025.
AXT, Inc. filed an S-3 shelf registration to offer up to $100,000,000 of securities from time to time after effectiveness. The mixed shelf may include common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts and units, with specific terms to be set in future supplements.
AXT’s common stock trades on the Nasdaq Global Select Market under the symbol AXTI. AXT states it believes no PRC central government permissions are required to complete this offering, while noting its manufacturing is conducted by PRC subsidiaries and joint ventures and highlighting related legal and operational risks. Unless otherwise specified in a supplement, net proceeds will be used for working capital and general corporate purposes. Securities may be sold directly or via agents, underwriters or dealers, with pricing determined at the time of each offering. The company does not anticipate paying cash dividends and qualifies as a smaller reporting company.
AXT Inc. (AXTI) reported an insider transaction by a director. On 11/05/2025, the director executed an open-market sale (code S) of 100,000 shares of common stock at $8.9404 per share. Following the sale, the director directly beneficially owns 207,744 shares. The filing indicates the form was submitted by one reporting person.